share_log

Matinas BioPharma | 8-K: Matinas BioPharma Reports Fourth Quarter and Full Year 2021 Financial Results and Operational Highlights

SEC ·  Mar 8, 2022 06:30
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more